Ever since URL Pharma got FDA approval for marketing COLCRYS for treatment of gout, generic colchicine has been unavailable or no longer covered by insurance and not prescribed.
URL claims that there is no generic form of COLCRYS — whose active ingredient is indeed colchicine. They base that on a literal definition of “generic,” which defines generic as an FDA-aproved drug that is now off-patent and approved to be sold as a generic drug rather than as a brandname drug.
But colchicine has been around for ages. According to Wikipedia, colchicum extract was first described as a treatment for gout in De Materia Medica by Pedanius Dioscorides in the first century.
Many gout sufferers — including Medicare recipients such as my brother — have to pay as much as $51 per month vs half that when they were able to buy colchicine off the shelf in pharmacies.
I think this is a travesty and an example of how drug companies are increasing the cost of health care in this country. What do you think?
Liked by Anonymous